July 10, 2019
ANDHealth, an Australian organisation dedicated to supporting digital health companies in their commercialisation journey, has partnered with a consortium of leading medical research institutes and universities in Western Australia (WA), led by the Telethon Kids Institute, as part of the State’s first Digital Health Accelerator Program.
Under the new partnership, ANDHealth will deliver its BRIGHT...
From left to right: Wojciech Radomski, StethoMe CEO and cofounder, Dario Mazzella, META Group innovation expert, Friedrich Lämmel, Thryve CEO and cofounder
June 12, 2019
Last week, Santosh Mohan, managing director of the Brigham Digital Innovation Hub, cautioned during an Enterprise Insights Series event in Boston that the digital health market was still in its “early days”, with many expectations unfulfilled as of yet.
“I want to say we are not in an investment bubble. I think the digital health solutions have started to show value and we are moving beyond...
May 16, 2019
Express Scripts will be releasing a stand-alone formulary in 2020 that highlights vetted digital health tools for the pharmacy benefit management firm’s payer and consumer customers, according to an announcement released this morning.
The company said that it will be treating the new formulary in much the same way it would a similar resource for traditional medications. To be included, a digital...
May 16, 2019
About the author: Joe Slavinsky leads business development efforts with pharmaceutical, biotechnology and medical technology companies in his VP position at Propeller Health. A former epidemiologist, he worked at a hedge fund (Citadel) and an investment bank (Thomas Weisel Partners) as an equity research analyst covering small/mid-cap biotechnology companies. Joe joined Propeller from Gilead...
May 15, 2019
Industry disruption by digital players is a major threat to the health insurance industry, but insurers themselves seem to be more dazzled by the oncoming glare than galvanised behind comprehensive strategies and best-practice development frameworks for digitising their businesses.
While there is a general cohesion around CRM and the customer experience, the deeper benefits of digitisation –...
May 14, 2019
The American Medical Association has always had an interesting relationship with digital health, vacillating between gadfly and cheerleader as it seeks to fulfill its role as the voice of physicians in industry conversations.
At the Cleveland Clinic Patient Experience: Empathy and Innovation Summit, an event held in Cleveland this week and organized in conjunction with HIMSS, AMA Board Chair Dr....
May 8, 2019
A randomized controlled trial recently published in npj Digital Medicine found Kaia Health’s app-based exercise therapy for lower back pain (LBP) to be an effective treatment for multidisciplinary patients, and could be more effective than a standard strategy of individual physiotherapy sessions paired with online education.
In the investigation — which was sponsored by Kaia Health...
April 30, 2019
When we talk about health consumerism or the consumerization of health, the topic encompasses a lot of disparate ideas. In her new book Health Consuming: From Health Consumer to Health Citizen, Jane Sarasohn-Kahn, a health economist with a 30-year background in the space, seeks to tie those ideas into one cohesive narrative — and to follow that narrative to see where it leads into our future.
Photo illustration by Jonah Comstock
April 18, 2019
Israel and Finland — two countries that have notably made digital health a focus of their economies — announced this week that they will work together to advance the field, starting with a Call for Proposals for joint projects between Finnish and Israeli companies.
The pilot project is being led by Helsinki Business Hub and the Israeli Innovation Authority, which will offer funding and services...
April 9, 2019
Although still in its earliest chapters, the story of digital therapeutics is beginning to pick up steam. Just six months ago, that the first software-only therapeutic cleared by the FDA, Pear Therapeutics’ reSET, kicked off a commercial launch driven by the sales channels expertise of an established pharmaceutical partner.
Proteus, meanwhile, recently expanded dealings with its long-time pharma...